![Peter Davies](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Davies
Directeur/Bestuurslid bij
Bionomics Ltd.
Vermogen: 669 $ op 31-05-2026
Profiel
Peter Miles Winston Davies is currently an Independent Non-Executive Director at Bionomics Ltd. since 2021, an Independent Non-Executive Director at Neuphoria Therapeutics, Inc. since 2024, and Chief Business Officer at Leaf4life, Inc. Formerly, Mr. Davies was Managing Director at Apeiron Investment Group Ltd. from 2021 to 2022.
Education includes graduation from The University of Edinburgh.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0% | 20-01-2026 | 126 ( 0% ) | 669 $ | 31-05-2026 |
Actieve functies van Peter Davies
| Bedrijven | Functie | Begin |
|---|---|---|
Bionomics Ltd.
 Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Directeur/Bestuurslid | 01-07-2021 |
Leaf4life, Inc. | Corporate Officer/Principal | - |
Eerdere bekende functies van Peter Davies
| Bedrijven | Functie | Einde |
|---|---|---|
Apeiron Investment Group Ltd.
 Apeiron Investment Group Ltd. Investment ManagersFinance Apeiron Investment Group invests in both public and private companies located across the globe primarily in the United States. The firm targets companies operating across a broad range of sectors and industries. It participates in pre-seed, seed, early, later and growth stage transactions. The firm invests in funds. It also acquires minority interest. | Private Equity Investor | 01-01-2022 |
Opleiding van Peter Davies
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apeiron Investment Group Ltd.
Apeiron Investment Group Ltd. Investment ManagersFinance Apeiron Investment Group invests in both public and private companies located across the globe primarily in the United States. The firm targets companies operating across a broad range of sectors and industries. It participates in pre-seed, seed, early, later and growth stage transactions. The firm invests in funds. It also acquires minority interest. | Finance |
Leaf4life, Inc. | Commercial Services |
